Mucosal delivery of RNA vaccines by Newcastle disease virus vectors
The rapid evolution of SARS-CoV-2 since its pandemic outbreak has underscored the need for improved SARS-CoV-2 vaccines that efficiently reduce not only hospitalizations and deaths, but also infections and transmission. This might be achieved by a new generation of intranasally administered SARS-CoV...
Main Author: | Adolfo García-Sastre |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Current Research in Immunology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590255522000221 |
Similar Items
-
Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
by: Shin-Hee Kim, et al.
Published: (2019-03-01) -
Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
by: Sohini Dey, et al.
Published: (2017-09-01) -
Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus
by: S. Chimeno Zoth, et al.
Published: (2008-04-01) -
Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
by: Edris Shirvani, et al.
Published: (2020-07-01) -
Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
by: Julia P. C. Fulber, et al.
Published: (2022-05-01)